Discover new ways to advance your oncology research this autumn. From KRAS drug discovery and PTM analysis to immune cell cytotoxicity research, explore innovative technologies such as BlueWhale Bio’s Synecta T1, alongside smarter cell line access solutions and expert resources to accelerate your projects from discovery to development.
Tebubio's CRO Services
KRAS Drug Discovery & Screening Capabilities
Explore how Tebubio CRO capabilities can support oncology drug discovery, from target-focused biochemical assays to cell-based screening and functional profiling.
Tebubio's Brochure
Advancing Research This Autumn
Explore our Autumn 2026 Highlights Brochure, bringing together innovative products, expert services, and smarter procurement solutions to help you work faster, simplify your workflows, and accelerate the path from discovery to results.
Product Highlights
Streamline PTM analysis with Signal-Seeker®
Discover validated reagents for the enrichment and detection of post-translational modifications, enabling reliable results with high specificity and streamlined workflows.
Advance immune cell cytotoxicity research
Explore sensitive, reliable assays for measuring immune cell-mediated cytotoxicity in CAR-T, CAR-NK and ADCC research, helping you evaluate effector cell activity and therapeutic responses.
Seamless cell line access for CRO projects
Accelerate CRO projects with Cytion’s cell line portfolio through the Tebubio Umbrella Contract, simplifying licensing and enabling faster project initiation.
Innovative Technology
Expanding access to next-generation cell therapy technologies
Tebubio is proud to partner with BlueWhale Bio to bring innovative T-cell activation solutions to researchers across Europe. This collaboration expands access to next-generation technologies that simplify cell therapy manufacturing and support the development of more consistent, high-quality engineered T cells.
Knowledge Resources
Recorded Webinars
[Case Study] Tracking tools for mRNA research
-
mRNA production
-
LNP formulation
-
3D models
-
Q&A session with project managers
Development of TCR-T and CAR-T cells
-
New suite of tools supporting CAR-T and TCR-T cell R&D
-
Primary human immune cells
In vivo drug delivery with Certest lipids
-
Advanced strategies
-
Certest Pharma’s proprietary lipids
-
Technology adaptation
Stay Ahead in Your Research
Subscribe to our monthly newsletter for the latest breakthroughs, expert insights, and exclusive updates in key research areas.